This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock UPTD vs. SLXN, TSBX, ALBT, PMCB, OMGA, AIM, CHRO, FRTX, KLTO, and CELZShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Silexion Therapeutics (SLXN), Turnstone Biologics (TSBX), Avalon GloboCare (ALBT), PharmaCyte Biotech (PMCB), Omega Therapeutics (OMGA), AIM ImmunoTech (AIM), Chromocell Therapeutics (CHRO), Fresh Tracks Therapeutics (FRTX), Klotho Neurosciences (KLTO), and Creative Medical Technology (CELZ). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. Silexion Therapeutics Turnstone Biologics Avalon GloboCare PharmaCyte Biotech Omega Therapeutics AIM ImmunoTech Chromocell Therapeutics Fresh Tracks Therapeutics Klotho Neurosciences Creative Medical Technology Silexion Therapeutics (NASDAQ:SLXN) and TradeUP Acquisition (NASDAQ:UPTD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment. Does the media refer more to SLXN or UPTD? In the previous week, Silexion Therapeutics had 6 more articles in the media than TradeUP Acquisition. MarketBeat recorded 6 mentions for Silexion Therapeutics and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat Silexion Therapeutics' score of -0.32 indicating that TradeUP Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Silexion Therapeutics Neutral TradeUP Acquisition Positive Which has better earnings & valuation, SLXN or UPTD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilexion TherapeuticsN/AN/A$260KN/AN/ATradeUP AcquisitionN/AN/A-$1MN/AN/A Which has more risk & volatility, SLXN or UPTD? Silexion Therapeutics has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500. Comparatively, TradeUP Acquisition has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Do insiders and institutionals hold more shares of SLXN or UPTD? 10.9% of Silexion Therapeutics shares are held by institutional investors. Comparatively, 35.0% of TradeUP Acquisition shares are held by institutional investors. 33.0% of Silexion Therapeutics shares are held by company insiders. Comparatively, 55.1% of TradeUP Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer SLXN or UPTD? Silexion Therapeutics received 2 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformSilexion TherapeuticsOutperform Votes266.67% Underperform Votes133.33% TradeUP AcquisitionN/AN/A Is SLXN or UPTD more profitable? Company Net Margins Return on Equity Return on Assets Silexion TherapeuticsN/A N/A -249.43% TradeUP Acquisition N/A N/A -3.38% Do analysts prefer SLXN or UPTD? Silexion Therapeutics currently has a consensus target price of $5.00, suggesting a potential upside of 380.77%. Given Silexion Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Silexion Therapeutics is more favorable than TradeUP Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silexion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TradeUP Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySilexion Therapeutics beats TradeUP Acquisition on 6 of the 11 factors compared between the two stocks. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.26M$2.92B$5.33B$8.31BDividend YieldN/A1.63%5.27%4.09%P/E RatioN/A31.0126.7119.58Price / SalesN/A395.76395.60135.07Price / CashN/A168.6838.3234.62Price / Book-0.653.236.764.50Net Income-$1M-$72.35M$3.23B$248.40M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$1.04+4.0%N/A-1.5%$2.26MN/A0.002,021Gap UpSLXNSilexion TherapeuticsN/A$0.99+7.1%$5.00+407.3%N/A$8.57MN/A0.00N/ANews CoverageTSBXTurnstone Biologics2.8581 of 5 stars$0.34+1.4%$0.45+32.6%-87.1%$7.85M$19.31M-0.1082ALBTAvalon GloboCare0.5637 of 5 stars$3.84+1.6%N/A-16.5%$7.27M$1.37M-0.195News CoverageUpcoming EarningsGap DownPMCBPharmaCyte Biotech1.1622 of 5 stars$1.02-2.1%N/A-52.1%$7.00MN/A1.924OMGAOmega Therapeutics2.3049 of 5 stars$0.13-21.8%$9.20+7,260.0%-94.1%$6.92M$8.10M-0.09120Gap UpAIMAIM ImmunoTech1.5717 of 5 stars$0.09-22.3%$2.75+2,908.8%-77.0%$6.61M$170,000.00-0.1920Gap DownHigh Trading VolumeCHROChromocell TherapeuticsN/A$0.96-3.5%N/A-31.7%$6.30MN/A-0.774Gap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+2.7%$5.59M$10.06M-0.6620KLTOKlotho NeurosciencesN/A$0.19+5.0%N/AN/A$5.29MN/A-0.53N/AGap UpCELZCreative Medical TechnologyN/A$1.96-1.0%N/A-54.1%$5.12M$14,000.00-0.525 Related Companies and Tools Related Companies Silexion Therapeutics Alternatives Turnstone Biologics Alternatives Avalon GloboCare Alternatives PharmaCyte Biotech Alternatives Omega Therapeutics Alternatives AIM ImmunoTech Alternatives Chromocell Therapeutics Alternatives Fresh Tracks Therapeutics Alternatives Klotho Neurosciences Alternatives Creative Medical Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPTD) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPTD Stock Free UPTD Stock Alerts